J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
Actelion - Wikipedia
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
Jean-Paul Clozel | EY - Global
PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia (October 2017)
Martine et Jean-Paul Clozel, le couple vedette de la pharmacie mondiale
Der Manager des Jahres heisst Jean-Paul Clozel | Finanz und Wirtschaft
Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm - WSJ
Jean-Paul Clozel, CEO Actelion - YouTube
Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Actelion-Gründer ausgezeichnet – Berührende Würdigung eines Erfolgs-Teams | Basler Zeitung
J&J/Actelion: high pressure sale | Financial Times
Actelion never made offer for ZS Pharma: CEO
Profile: Jean-Paul Clozel | Nature Biotechnology
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Actelion Could Boost Takeover Price for Johnson & Johnson
Was plant das Ehepaar Clozel? | NZZ
Biotech: Jean-Paul Clozel kämpft bei Idorsia mit Gegenwind
Molecular Millionaire: Jean-Paul Clozel of Actelion
Big Boss - Jean-Paul Clozel, CEO Idorsia - Play RTS
Actelion's Fate May Rest on Structure, Not Price, as Clozel Holds Firm - TheStreet
Actelion: Die Knackpunkte eines Deals mit Johnson & Johnson | Tages-Anzeiger
